Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Stroke

  Free Subscription


Articles published in Am J Med

Retrieve available abstracts of 26 articles:
HTML format
Text format



Single Articles


    October 2018
  1. HENNEMEYER C, Khan A, McGregor H, Moffett C, et al
    Outcomes of Catheter Directed Therapy Plus Anticoagulation Versus Anticoagulation Alone for Submassive and Massive Pulmonary Embolism with Subgroup Analysis.
    Am J Med. 2018 Oct 24. pii: S0002-9343(18)31032.
    PubMed     Text format     Abstract available


    May 2018
  2. ADAMS K, Kearney M, Lee K, Rhoney D, et al
    Strength in Numbers: A Team-Based Approach to Managing Patients with Hyponatremia.
    Am J Med. 2018 May 24. pii: S0002-9343(18)30438.
    PubMed     Text format     Abstract available


    January 2018
  3. LEVIN SN, Lyons JL
    Infections of the Nervous System.
    Am J Med. 2018;131:25-32.
    PubMed     Text format     Abstract available


    December 2017
  4. MELLONI C, Dunning A, Granger CB, Thomas L, et al
    Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial.
    Am J Med. 2017;130:1440-1448.
    PubMed     Text format     Abstract available


    November 2017
  5. NAZZAL S, Hijazi B, Khalila L, Blum A, et al
    Diagonal Earlobe Crease (Frank's Sign): A Predictor of Cerebral Vascular Events.
    Am J Med. 2017;130:1324.
    PubMed     Text format     Abstract available


    September 2017
  6. FANIKOS J, Burnett AE, Mahan CE, Dobesh PP, et al
    Renal Function Considerations for Stroke Prevention in Atrial Fibrillation.
    Am J Med. 2017;130:1015-1023.
    PubMed     Text format     Abstract available


    July 2017
  7. POTPARA TS, Lip GYH, Blomstrom-Lundqvist C, Chiang CE, et al
    Viewpoint: Stroke Prevention in Recent Guidelines for the Management of Patients with Atrial Fibrillation: An Appraisal.
    Am J Med. 2017;130:773-779.
    PubMed     Text format     Abstract available


    June 2017
  8. BANGALORE S, Toklu B, Gianos E, Schwartzbard A, et al
    Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials.
    Am J Med. 2017;130:707-719.
    PubMed     Text format     Abstract available


    April 2017
  9. RENDA G, Ricci F, De Caterina R
    Non-Vitamin K Antagonist Oral Anticoagulants for Cardioversion in Atrial Fibrillation: An Updated Meta-analysis.
    Am J Med. 2017;130:457-461.
    PubMed     Text format     Abstract available


    March 2017
  10. DALEN JE, Alpert JS
    Silent Atrial Fibrillation and Cryptogenic Strokes.
    Am J Med. 2017;130:264-267.
    PubMed     Text format     Abstract available


  11. BARBARYAN A, Bailuc S, Raqeem MW, Kak M, et al
    Wake-Up Call: Pulmonary Arteriovenous Malformation.
    Am J Med. 2017;130:290-292.
    PubMed     Text format    


    February 2017
  12. MAZUREK M, Huisman MV, Lip GY
    Registries in Atrial Fibrillation: From Trials to Real-Life Clinical Practice.
    Am J Med. 2017;130:135-145.
    PubMed     Text format     Abstract available


    December 2016
  13. BIENER M, Giannitsis E, Kuhner M, Zelniker T, et al
    Prognostic value of high-sensitivity cardiac troponin T compared to riskscores in stable cardiovascular disease.
    Am J Med. 2016 Dec 20. pii: S0002-9343(16)31242.
    PubMed     Text format     Abstract available


  14. FAUCHIER L, Villejoubert O, Clementy N, Bernard A, et al
    Causes of Death and Influencing Factors in Patients with Atrial Fibrillation.
    Am J Med. 2016;129:1278-1287.
    PubMed     Text format     Abstract available


    November 2016
  15. DE SOUZA BRITO F, Mehta RH, Lopes RD, Harskamp RE, et al
    Non-Steroidal Anti-Inflammatory Drugs and Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Surgery.
    Am J Med. 2016 Nov 22. pii: S0002-9343(16)31197.
    PubMed     Text format     Abstract available


  16. DALEN JE, Alpert JS
    Cryptogenic Strokes and Patent Foramen Ovales: What's the Right Treatment?
    Am J Med. 2016;129:1159-1162.
    PubMed     Text format     Abstract available


  17. BARRA ME, Fanikos J, Connors JM, Sylvester KW, et al
    Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy.
    Am J Med. 2016;129:1198-1204.
    PubMed     Text format     Abstract available


  18. EIKELBOOM J, Merli G
    Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical Experience.
    Am J Med. 2016;129.
    PubMed     Text format     Abstract available


  19. MILLING TJ JR, Kaatz S
    Preclinical and Clinical Data for Factor Xa and "Universal" Reversal Agents.
    Am J Med. 2016;129.
    PubMed     Text format     Abstract available


  20. VILLINES TC, Peacock WF
    Safety of Direct Oral Anticoagulants: Insights from Postmarketing Studies.
    Am J Med. 2016;129.
    PubMed     Text format     Abstract available


  21. MILLING TJ JR, Spyropoulos AC
    Re-Initiation of Dabigatran and Direct Factor Xa Antagonists After a Major Bleed.
    Am J Med. 2016;129.
    PubMed     Text format     Abstract available


    October 2016
  22. ALEXANDER GC, Iyer G, Lucas E, Lin D, et al
    Cardiovascular risks of exogenous testosterone use among men: A systematic review and meta-analysis.
    Am J Med. 2016 Oct 14. pii: S0002-9343(16)31024.
    PubMed     Text format     Abstract available


  23. RENDA G, Zimarino M, Ricci F, Piccini JP, et al
    Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation.
    Am J Med. 2016;129:1117-1123.
    PubMed     Text format     Abstract available


  24. PEREG D, Rozenbaum Z, Vorobeichik D, Shlomo N, et al
    Prevalence and Significance of Unrecognized Renal Dysfunction in Patients with Stroke.
    Am J Med. 2016;129:1074-81.
    PubMed     Text format     Abstract available


  25. PROIETTI M, Lip GY
    Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range Observations from the SPORTIF Trials.
    Am J Med. 2016;129:1110-6.
    PubMed     Text format     Abstract available


    May 2016
  26. RUFF CT, Ansell JE, Becker RC, Benjamin EJ, et al
    North American Thrombosis Forum, AF Action Initiative Consensus Document.
    Am J Med. 2016;129.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: